RecruitingNot ApplicableNCT06025331

Does BIO-RSA Provides Superior Clinical Outcome Compared to Conventional RSA?

From Cuff Arthropathy to Reverse Shoulder Arthroplasty - a Multicentre Randomized Control Trial (Study 1: Does BIO-RSA Provides Superior Clinical Outcome Compared to Conventional RSA?).


Sponsor

Lovisenberg Diakonale Hospital

Enrollment

130 participants

Start Date

Sep 15, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical trial is to compare two different types of reverse shoulder replacements. Researchers will compare a conventional reverse shoulder replacement with a lateralized reverse shoulder replacement to see if there is a difference in how well the patients function after two years.


Eligibility

Min Age: 45 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called BIO-RSA and a procedure called RSA for people with arthroplasty, replacement, shoulder and shoulder osteoarthritis. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 45 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREBIO-RSA

Bony increased offset-reversed shoulder arthroplasty(BIO-RSA) will be performed.

PROCEDURERSA

Conventional reversed shoulder arthroplasty(RSA) will be performed.


Locations(2)

Sykehuset Telemark HF

Skien, Telemark, Norway

Lovisenberg Diaconal Hospital

Oslo, Norway

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06025331


Related Trials